Solara Active PP

How has been the historical performance of the Solara Active PP?

No Data Available for this Stock

how big is Solara Active PP?

As of June 06, Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 389.00 Cr, categorizing it as a Micro Cap. There is no available financial data for the latest four quarters or balance sheet information.

Market Cap: As of June 06, Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 389.00 Cr, categorizing it as a Micro Cap.<BR><BR>Recent Quarterly Performance: As of June 06, there is no valid Consolidated or Standalone financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: As of June 06, there is no valid Consolidated or Standalone balance sheet data available, including values for Shareholder's Funds and Total Assets for the latest annual period.

When is the next results date for Solara Active PP?

No Upcoming Board Meetings

Has Solara Active PP declared dividend?

No Dividend History Available

What is the technical trend for Solara Active PP?

As of June 4, 2025, Solara Active PP shows a neutral trend with a slight bullish inclination due to a mildly bullish weekly MACD and RSI, despite daily moving averages being mildly bearish and no clear trend from Dow Theory and OBV.

As of 4 June 2025, the technical trend for Solara Active PP has changed from mildly bearish to sideways. The weekly MACD is mildly bullish, and the RSI is bullish, indicating some positive momentum in the short term. However, daily moving averages are mildly bearish, suggesting caution. The Bollinger Bands on the weekly chart are also bullish, supporting the upward potential. Dow Theory and OBV show no clear trend in both weekly and monthly time frames, indicating a lack of strong directional movement. Overall, the current stance is neutral with a slight bullish inclination, driven primarily by the weekly MACD and RSI.

Who are the peers of the Solara Active PP?

Peers of Solara Active PP include Venus Remedies, Ind-Swift Labs, Jenburkt Pharma, Zim Laboratories, Albert David, Medicamen Biotec, Valiant Laborato, Brooks Lab, Nectar Lifesci, and Infinium Pharma. Jenburkt Pharma has the highest 1-year return at 47.73%, while Solara Active PP leads with 59.14%.

Peers: The peers of Solara Active PP are Venus Remedies, Ind-Swift Labs., Jenburkt Pharma, Zim Laboratories, Albert David, Medicamen Biotec, Valiant Laborato, Brooks Lab., Nectar Lifesci., and Infinium Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Infinium Pharma, while Average management risk is found at Venus Remedies, Jenburkt Pharma, Zim Laboratories, Albert David, Medicamen Biotec, and the rest. Below Average management risk is present at Ind-Swift Labs., Valiant Laborato, Brooks Lab., and Nectar Lifesci. Growth is rated as Excellent for Venus Remedies, Jenburkt Pharma, Albert David, Medicamen Biotec, and the rest show Below Average growth, including Ind-Swift Labs., Zim Laboratories, and Valiant Laborato. Infinium Pharma stands out with Good growth. Capital Structure is Excellent for Venus Remedies, Jenburkt Pharma, Albert David, Medicamen Biotec, and the rest, while Average is noted for Zim Laboratories, and Below Average for Ind-Swift Labs., Valiant Laborato, Brooks Lab., and Nectar Lifesci.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Jenburkt Pharma at 47.73%, while Ind-Swift Labs. has the lowest at -26.31%. Solara Active PP's 1-year return of 59.14% is higher than both of these peers. Additionally, several peers, including Ind-Swift Labs., Albert David, Medicamen Biotec, Valiant Laborato, Brooks Lab., Nectar Lifesci., and Infinium Pharma, have negative six-month returns.

What does Solara Active PP do?

Solara Active Pharma Sciences Ltd Partly Paidup is a micro-cap company in the Pharmaceuticals & Biotechnology sector with no reported sales or profits. It has a market cap of INR 541 Cr and key metrics such as a P/E ratio and dividend yield of 0.00%.

Overview: <BR>Solara Active Pharma Sciences Ltd Partly Paidup operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not provided. There are no reported sales or profit figures for the latest quarter.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 541 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 37 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 0.00% <BR>Price-to-Book: 0.00<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Why is Solara Active Pharma Sciences Ltd Partly Paidup falling/rising?

As of 03-Apr, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is stable at Rs 308.70, with recent short-term gains despite an 18.78% year-to-date decline. Concerns about falling investor participation and mixed signals from moving averages suggest a cautious outlook.

As of 03-Apr, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is currently stable at Rs 308.70, showing no change (0.00%). Despite this stability, the stock has demonstrated a positive performance in the short term, outperforming the sector by 13.15% today and opening with a significant gain of 12.87%. The stock reached an intraday high of Rs 308.70, indicating strong initial interest.<BR><BR>However, the stock's overall year-to-date performance shows a decline of 18.78%, which is worse than the benchmark Sensex's decline of 13.96%. Over the past week and month, the stock has shown positive returns of 2.56% and 2.47%, respectively, while the Sensex has fallen by 2.60% and 8.62% during the same periods. This indicates that while the stock is currently stable, it has been recovering recently compared to the broader market.<BR><BR>Despite the positive short-term performance, there are concerns regarding falling investor participation, as evidenced by a 14.1% decrease in delivery volume compared to the 5-day average. Additionally, the stock is trading above its 5-day and 20-day moving averages but below its longer-term moving averages (50-day, 100-day, and 200-day), suggesting mixed signals about its longer-term trend.<BR><BR>In summary, while the stock is currently stable and has shown recent gains, its year-to-date decline and decreasing investor participation may contribute to a cautious outlook.

Why is Solara Active Pharma Sciences Ltd Partly Paidup falling/rising?

As of 04-Apr, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is stable at Rs 308.70, with recent positive returns of +2.56% and +2.47% over the last week and month, respectively. However, declining trading activity and delivery volumes indicate caution among investors, potentially limiting upward momentum.

As of 04-Apr, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is currently stable at Rs 308.70, showing no change (0.00%). However, the stock has demonstrated a positive performance in recent periods, particularly over the last week and month, with returns of +2.56% and +2.47%, respectively, while the benchmark Sensex has declined by -2.60% and -8.62% during the same periods. <BR><BR>Today, the stock opened with a significant gain of 12.87%, reaching an intraday high of Rs 308.70, indicating strong initial investor interest. Despite this positive opening, the stock has not fluctuated from this price throughout the trading day. <BR><BR>It is important to note that the stock has been experiencing erratic trading, having not traded on one day out of the last 20 days, which may contribute to a perception of volatility. Additionally, there has been a decline in investor participation, with delivery volume falling by -14.1% compared to the 5-day average, which could indicate a lack of sustained buying interest. <BR><BR>Overall, while the stock has shown some positive movements recently, the lack of trading activity and declining delivery volumes suggest caution among investors, which may temper any significant upward momentum in the stock price.

Why is Solara Active Pharma Sciences Ltd Partly Paidup falling/rising?

As of 05-Apr, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is at 308.70, showing a recent weekly increase of 2.56%. Despite a strong opening today, the stock's lack of upward momentum and declining investor participation may hinder its ability to sustain gains.

As of 05-Apr, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is currently at 308.70, with no change from the previous trading session. The stock has shown a positive performance recently, with a weekly increase of 2.56% and a monthly increase of 2.47%, outperforming the benchmark Sensex, which has declined by 2.60% and 8.62% respectively over the same periods. <BR><BR>Today, the stock opened with a significant gain of 12.87%, reaching an intraday high of Rs 308.70. This indicates strong initial investor interest. However, despite this positive opening, the stock has not traded above this price throughout the day, suggesting a lack of upward momentum following the initial surge. <BR><BR>It is important to note that the stock has experienced erratic trading, having not traded on one day out of the last 20 days, which may contribute to volatility in its price movements. Additionally, there has been a decline in investor participation, with delivery volume falling by 14.1% compared to the 5-day average, indicating a potential decrease in demand. <BR><BR>Overall, while the stock has shown some positive short-term performance and opened strongly today, the falling investor participation and erratic trading patterns may temper the stock's ability to maintain upward momentum in the near term.

Which are the latest news on Solara Active PP?